Latest News, Announcements, and Press Releases

REDWOOD CITY, Calif. , July 30, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report second quarter 2020 financial results after market close on Thursday, August 6, 2020 . Codexis management…

Partnership targets accelerating the commercialization of enzymatic DNA synthesis: Codexis invests cash and protein engineering for equity stake in Molecular Assemblies REDWOOD CITY, Calif. and SAN DIEGO , June 23, 2020 (GLOBE NEWSWIRE) — Codexis, Inc.

REDWOOD CITY, Calif. , June 16, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, announces the election of new independent directors, Alison Moore , Ph.D. and Stephen Dilly , MBBS,…

First enzymes will target NGS-based diagnostics, RNA-directed viral diagnostics and RNA manufacturing REDWOOD CITY, Calif. and JUPITER, Fla. , June 01, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and

REDWOOD CITY, Calif. , May 27, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate in two virtual investment conferences: 17 th Annual Craig-Hallum Institutional Investor Conference being held in a…

REDWOOD CITY, Calif. , May 11, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will present at the UBS Virtual Healthcare Conference on Monday, May 18 at 9:10 a.m. Eastern time (…

R&D revenue increased 26% to $9 .6 million fueled by the Novartis and Takeda strategic collaborations Withdraws 2020 financial guidance due to uncertainty of COVID-19 potential impact Conference call begins at 4:30 pm Eastern time today REDWOOD CITY, Calif.

REDWOOD CITY, Calif. , May 06, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. , a leading protein engineering company and developer of novel biotherapeutics, announces achievement of the Wave 2 milestone associated with the CodeEvolver ® platform technology transfer and license…

REDWOOD CITY, Calif. , May 05, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. , a leading protein engineering company and developer of novel biotherapeutics, announces the appointment of Stefan Lutz , Ph.D. as Senior Vice President, Research and Karl A. Schoene…

REDWOOD CITY, Calif. , April 30, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report first quarter 2020 financial results after market close on Thursday, May 7, 2020 .  Codexis management…